Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters

Korian: H1 results: In line with expectations

BUY, Fair Value EUR34 (+13%)

Published last September Thursday 17, 2015
Bryan, Garnier & Co. Gmbh advised Qelp on Acquisition by SYKES Enterprises

Bryan, Garnier & Co. Gmbh advised Qelp on Acquisition by SYKES Enterprises

Published last September Friday 11, 2015
Bryan, Garnier & Co advises Netco Sports’ shareholders on the sale of the company to Euro Media Group

Bryan, Garnier & Co advises Netco Sports’ shareholders on the sale of the company to Euro Media Group

Published last September Thursday 10, 2015
Bryan, Garnier & Co advises the sale of SynerTrade to Digital Dimension

Bryan, Garnier & Co advises the sale of SynerTrade to Digital Dimension

Published last September Tuesday 1, 2015

Pernod Ricard: FY results slightly below consensus but in line with company guidance

BUY, Fair Value EUR132 (+41%)

Published last August Thursday 27, 2015

LVMH: A Buy opportunity

BUY, Fair Value EUR186 (+28%)

Published last August Thursday 27, 2015

Ablynx: Ablynx to go alone with caplacizumab

CORPORATE, Fair Value EUR16 (+34%)

Published last August Thursday 27, 2015

Adocia: Last planned phase Ib/IIa study with BC lispro initiated

BUY, Fair Value EUR113 (+37%)

Published last August Thursday 27, 2015

Gemalto: H1 sales above estimates but disappointing margins

NEUTRAL, Fair Value EUR83 (+12%)

Published last August Thursday 27, 2015

China’s stress test: we favour Essilor, Luxottica and Hugo Boss!

Published last August Thursday 27, 2015

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities